相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Heparanase Regulatory Network in Health and Disease
Alyce J. Mayfosh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Rheumatoid arthritis: Extra-articular manifestations and comorbidities
Fabiana Assunta Figus et al.
AUTOIMMUNITY REVIEWS (2021)
Macrophages bind LDL using heparan sulfate and the perlecan protein core
Chun-yi Ng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Management of Rheumatoid Arthritis: An Overview
Andrei-Flavius Radu et al.
CELLS (2021)
Circulating Heparan Sulfate Proteoglycans as Biomarkers in Health and Disease
Antonio Junior Lepedda et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2021)
Effect of Heparanase and Heparan Sulfate Chains in Hemostasis
Yona Nadir
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2021)
Cardiac Dysfunction in Rheumatoid Arthritis: The Role of Inflammation
Jianmin Chen et al.
CELLS (2021)
Vascular cell adhesion molecule-1 in rheumatoid arthritis patients Relation to disease activity, oxidative stress, and systemic inflammation
Heba R. Salem et al.
SAUDI MEDICAL JOURNAL (2021)
A Pilot Study: Hypertension, Endothelial Dysfunction and Retinal Microvasculature in Rheumatic Autoimmune Diseases
Ahmed Mahdy et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Chondroitin Sulfate/Dermatan Sulfate-Protein Interactions and Their Biological Functions in Human Diseases: Implications and Analytical Tools
Bin Zhang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Asymmetric and symmetric dimethylarginine concentration as an indicator of cardiovascular diseases in rheumatoid arthritis patients: a systematic review and meta-analysis of case-control studies
Parisa Zafari et al.
CLINICAL RHEUMATOLOGY (2020)
Significant Remodeling Affects the Circulating Glycosaminoglycan Profile in Adult Patients with both Severe and Mild Forms of Acute Pancreatitis
Ewa M. Kozma et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Aggrecan Turnover in Women with Rheumatoid Arthritis Treated with TNF-α Inhibitors
Anna Szeremeta et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Communications via the Small Leucine-rich Proteoglycans: Molecular Specificity in Inflammation and Autoimmune Diseases
Jinyang Zeng-Brouwers et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2020)
The Inter-α-Trypsin Inhibitor Family: Versatile Molecules in Biology and Pathology
Megan S. Lord et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2020)
Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis
Anne Grete Semb et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
Increased monocyte chemoattractant protein-1 and nitrotyrosine are associated with increased body weight in patients with rheumatoid arthritis after etanercept therapy
Hsien-Hao Huang et al.
NEUROPEPTIDES (2020)
ADMA: A Key Player in the Relationship between Vascular Dysfunction and Inflammation in Atherosclerosis
Laura Dowsett et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Breaking down chronic inflammatory diseases: the role of biglycan in promoting a switch between inflammation and autophagy
Heiko Roedig et al.
FEBS JOURNAL (2019)
Rheumatoid Arthritis
Jeffrey A. Sparks
ANNALS OF INTERNAL MEDICINE (2019)
The glycocalyx: a novel diagnostic and therapeutic target in sepsis
Ryo Uchimido et al.
CRITICAL CARE (2019)
The proteoglycan biglycan mediates inflammatory response by activating TLR-4 in human chondrocytes: Inhibition by specific siRNA and high polymerized Hyaluronan
Angela Avenoso et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2018)
The Role of Heparan Sulfate in Inflammation, and the Development of Biomimetics as Anti-Inflammatory Strategies
Brooke L. Farrugia et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2018)
Asymmetric Dimethyl Arginine as a Biomarker of Atherosclerosis in Rheumatoid Arthritis
Manuela Di Franco et al.
MEDIATORS OF INFLAMMATION (2018)
Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications
Bryant R. England et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications
Bryant R. England et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Rheumatoid arthritis
Josef S. Smolen et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Proteoglycan Chemical Diversity Drives Multifunctional Cell Regulation and Therapeutics
Nikos K. Kararnanos et al.
CHEMICAL REVIEWS (2018)
Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis
Unnikrishnan M. Chandrasekharan et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Effects of a 15-month anti-TNF-α treatment on plasma levels of glycosaminoglycans in women with rheumatoid arthritis
Anna Szeremeta et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Research Progress on the Relationship between Atherosclerosis and Inflammation
Yuhua Zhu et al.
BIOMOLECULES (2018)
Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology
Liliana Schaefer et al.
FEBS JOURNAL (2017)
Modulation of human monocyte/macrophage activity by tocilizumab, abatacept and etanercept: An in vitro study
Joyce Afrakoma Obeng et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Analytical Methods for Assessing Chondroitin Sulfate in Human Plasma
Veronica Mantovani et al.
JOURNAL OF AOAC INTERNATIONAL (2016)
Asymmetric dimethylarginine and arterial stiffness in patients with rheumatoid arthritis: A case-control study
Gian Luca Erre et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2016)
Soluble biglycan: a potential mediator of cartilage degradation in osteoarthritis
Goncalo Barreto et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Circulating glycosaminoglycan species in septic shock
A. Nelson et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2014)
Alterations of plasma glycosaminoglycan profile in patients with rheumatoid arthritis in relation to disease activity
Agnieszka Jura-Poltorak et al.
CLINICA CHIMICA ACTA (2014)
Decrease of Asymmetric Dimethyl Arginine After Anti-TNF Therapy in Patients with Rheumatoid Arthritis
Francesca Romana Spinelli et al.
DRUG DEVELOPMENT RESEARCH (2014)
Soluble biglycan induces the production of ICAM-1 and MCP-1 in human aortic valve interstitial cells through TLR2/4 and the ERK1/2 pathway
Rui Song et al.
INFLAMMATION RESEARCH (2014)
Endothelial Dysfunction in Chronic Inflammatory Diseases
Curtis M. Steyers et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Etanercept reduces the serum levels of macrophage chemotactic protein-1 in patients with rheumatoid arthritis
Yasunori Kageyama et al.
Modern Rheumatology (2014)
Heparan sulfate differences in rheumatoid arthritis versus healthy sera
Jenny K. Sabol et al.
MATRIX BIOLOGY (2014)
Differential Associations of Inflammatory and Endothelial Biomarkers with Disease Activity in Rheumatoid Arthritis of Short Duration
Ewa Klimek et al.
MEDIATORS OF INFLAMMATION (2014)
Soluble Heparan Sulfate Fragments Generated by Heparanase Trigger the Release of Pro-Inflammatory Cytokines through TLR-4
Katharine J. Goode et al.
PLOS ONE (2014)
Potential roles of vessel wall heparan sulfate proteoglycans in atherosclerosis
Rosalinda Madonna et al.
VASCULAR PHARMACOLOGY (2014)
Correlation between the severity of coronary artery lesions and levels of estrogen, hs-CRP and MMP-9
Changlei Guo et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2014)
Involvement of heparanase in atherosclerosis and other vessel wall pathologies
Israel Vlodavsky et al.
MATRIX BIOLOGY (2013)
Blood Monocyte Chemotactic Protein-1 (MCP-1) and Adapted Disease Activity Score28-MCP-1: Favorable Indicators for Rheumatoid Arthritis Activity
Lieh-bang Liou et al.
PLOS ONE (2013)
Determination of the Diagnostic Values of Asymmetric Dimethylarginine as an Indicator for Evaluation of the Endothelial Dysfunction in Patients with Rheumatoid Arthritis
Dejan Spasovski et al.
ARTHRITIS (2013)
Biglycan fragmentation in pathologies associated with extracellular matrix remodeling by matrix metalloproteinases
Federica Genovese et al.
FIBROGENESIS & TISSUE REPAIR (2013)
Clinical remission following treatment with tumour necrosis factor-alpha antagonists is not accompanied by changes in asymmetric dimethylarginine in patients with rheumatoid arthritis
Aamer Sandoo et al.
CLINICAL BIOCHEMISTRY (2012)
Serum Levels of Matrix Metalloproteinase (MMP) 9, a Risk Factor for Acute Coronary Syndrome, Are Reduced Independently of Serum MMP-3 by Anti-TNF-α Antibody (Infliximab) Therapy in Patients With Rheumatoid Arthritis
Takuya Kotani et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2012)
Serum Levels of Asymmetric Dimethylarginine and Apelin as Potential Markers of Vascular Endothelial Dysfunction in Early Rheumatoid Arthritis
Manuela Di Franco et al.
MEDIATORS OF INFLAMMATION (2012)
Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis
P. Fogelstrand et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2012)
Prothrombotic effects of tumor necrosis factor alpha in vivo are amplified by the absence of TNF-alpha receptor subtype 1 and require TNF-alpha receptor subtype 2
Joachim Pircher et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Association between Human Plasma Chondroitin Sulfate Isomers and Carotid Atherosclerotic Plaques
Elisabetta Zinellu et al.
BIOCHEMISTRY RESEARCH INTERNATIONAL (2012)
Serum chemokines in patients with rheumatoid arthritis treated with etanercept
Piotr Adrian Klimiuk et al.
RHEUMATOLOGY INTERNATIONAL (2011)
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
Daniel Aletaha et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Effects of Long-Term Disease-Modifying Antirheumatic Drugs on Endothelial Function in Patients with Early Rheumatoid Arthritis
M. Turiel et al.
CARDIOVASCULAR THERAPEUTICS (2010)
The role of endothelial function and its assessment in rheumatoid arthritis
Faisel Khan et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
Rheumatoid Arthritis - A Model of Systemic Inflammation Driving Atherosclerosis
Ivy A. Ku et al.
CIRCULATION JOURNAL (2009)
Role of TNF-α in vascular dysfunction
Hanrui Zhang et al.
CLINICAL SCIENCE (2009)
Vascular disease in rheumatoid arthritis: From subclinical lesions to cardiovascular risk
Coman Tanasescu et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2009)
The Disease Activity Score and the EULAR Response Criteria
Jaap Fransen et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2009)
Effect of etanercept on serum levels of soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor in patients with rheumatoid arthritis
P. A. Klimiuk et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2009)
Dramatic regulation of heparanase activity and angiogenesis gene expression in synovium from patients with rheumatoid arthritis
Rachel W. Li et al.
ARTHRITIS AND RHEUMATISM (2008)
Heparan Sulfate in Perlecan Promotes Mouse Atherosclerosis
Karin Tran-Lundmark et al.
CIRCULATION RESEARCH (2008)
Protein biochip array technology for cytokine profiling predicts etanercept responsiveness in rheumatoid arthritis
S. Fabre et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Long-lasting tissue inflammatory processes trigger autoimmune responses to extracellular matrix molecules
Roberto Bei et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2008)
Circulating Matrix Metalloproteinase-9 Is Associated with Cardiovascular Risk Factors in a Middle-Aged Normal Population
Peter Garvin et al.
PLOS ONE (2008)
Heparan sulfate regulates ephrin-A3/EphA receptor signaling
Fumitoshi Irie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Etanercept reduces the oxidative stress marker levels in patients with rheumatoid arthritis
Yasunori Kageyama et al.
RHEUMATOLOGY INTERNATIONAL (2008)
Reduced perlecan expression and accumulation in human carotid atherosclerotic lesions
Phan-Kiet Tran et al.
ATHEROSCLEROSIS (2007)
Advances in chondroitin sulfate analysis: Application in physiological and pathological states of connective tissue and during pharmacological treatment of osteoarthritis
N Volpi
CURRENT PHARMACEUTICAL DESIGN (2006)
CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the framingham heart study
DH McDermott et al.
CIRCULATION (2005)
Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis
PH Dessein et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Glycosaminoglycans are a potential cause of rheumatoid arthritis
JY Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Anti-tumour necrosis factor (TNF)-α therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis
AI Catrina et al.
RHEUMATOLOGY (2002)
Angiogenesis in rheumatoid arthritis
Ewa M. Paleolog
ARTHRITIS RESEARCH & THERAPY (2002)
Inflammation-induced systemic proteolysis of inter-α-inhibitor in plasma from patients with sepsis
M Balduyck et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2000)
分享论文
